Founded in 2009 as the International Consortium of Stem Cell Research (INCOSC), Boyalife Group is a privately-held global biopharmaceutical holding company with 30 subsidiaries and affiliated companies operating in three distinct business segments: 1) cellular processing and biobanking for regenerative medicine, CAR-T and other emerging immunotherapies, 2) genomics and 3) drug discovery. Boyalife Group is headquarted in Wuxi City, China, and maintains operations in Tianjin, Guangzhou, Beijing, Seoul, South Korea, New Delhi, India and Sacramento, California, USA.
Company Details
- Employees
- 42
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.boyalifegroup.com
Boyalife Questions
Boyalife's website is http://www.boyalifegroup.com
Boyalife's LinkedIn profile is https://cn.linkedin.com/company/%E5%8C%97%E5%A4%A7%E5%8D%9A%E9%9B%85%E6%8E%A7%E8%82%A1%E9%9B%86%E5%9B%A2
Boyalife has
42 employees.
View email and phone details for 42
employees at Boyalife.
Boyalife's industry is
Biotechnology Research
Boyalife's top competitors are
Confederated Tribes Of The Colville Reservation,
Infinimmune,
Som Biotech,
Birdwood Therapeutics,
Colossal Biosciences,
Viagen Pets & Equine,
Thermogenesis Holdings, Inc.,
Sinogene,
Advanbio,
Healthbanks Biotech.
Boyalife's categories are Biotechnology Research
Boyalife's founding year is 2009
